• A Nature paper on senolytic therapy was shared: “Targeted clearance of senescent cells using an antibody-drug conjugate against a specific membrane marker” (Sci. Rep. 2021) – the work demonstrates a method for precisely eliminating senescent cells via an antibody-drug conjugate, a potential longevity intervention.  
• A New Yorker profile of Peter Thiel was circulated (https://www.newyorker.com/news/letter-from-silicon-valley/what-is-it-about-peter-thiel), prompting implicit discussion about Thiel’s influence on transhumanist and longevity-startup ecosystems.